This combination peptide formulation contains 5mg BPC-157 and 5mg Thymosin Beta-4 (TB4) per vial. Provided as a sterile lyophilized powder for controlled reconstitution in laboratory settings.
Commonly investigated in preclinical research for roles in angiogenesis, cellular migration, and tissue repair mechanisms.



Reviews
There are no reviews yet.